Results 111 to 120 of about 16,277 (176)

Inequalities in the use of three-dose of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine among women in Sierra Leone, 2008-2019. [PDF]

Malar J
Osborne A, Bai-Sesay AU, Sesay U, Bangura C, Ahinkorah BO.   +4 more
europepmc   +1 more source

Intravitreal cotrimoxazole as adjuvant therapy for active ocular toxoplasmosis: a case series and literature review. [PDF]

J Ophthalmic Inflamm Infect
Hosseini SM, Azadmanesh A, Zamani G, Shariati MM.   +3 more
europepmc   +1 more source

Impact of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine on sexually transmitted and reproductive tract infections: results from a randomized trial in Uganda. [PDF]

Int J Epidemiol
Adrama H, Dela Cruz EJ, Ozarslan N, Kakuru A, Odongo B, Gaw SL, Benjamin-Chung J, Kizza J, Aguti M, Ategeka J, Olwoch P, Nakalembe M, Opira B, Clark TD, Kamya MR, Rosenthal PJ, Dorsey G, Roh ME.   +17 more
europepmc   +1 more source

Trends in Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine and amodiaquine over ten years of seasonal malaria chemoprevention in Moissala Health District, Chad. [PDF]

Malar J
Grandesso F, Diar MSI, Kouassi F, Sayyad-Hilario J, Ouedraogo P, Djimde AA, Singh S, Dama S.   +7 more
europepmc   +1 more source

Border Region Surveillance of Malaria Drug Resistance, Northern Burundi, 2023-2024. [PDF]

Emerg Infect Dis
Niyomwungere D, Sinarinzi P, Caspar E, Thiebaut L, Strubel PE, Tibiri YNG, Ma L, Rurihafi J, Ndizeyimana P, Hakizimana P, Niyizompa N, Witonze A, Ndayiragije V, Ndayisenga F, Ndikumukiza M, Niyonkuru O, Niyonsaba JC, Bangirinama C, Bigirimana JL, Ntahondi N, Mugisha L, Nibakire M, Nzoyikorera N, Sinzinkayo D, Menard D, Nyandwi J.   +25 more
europepmc   +1 more source

Effect of malaria chemoprevention for school-age children across transmission archetypes: a modelling study.

Lancet Glob Health
Suresh J, Zimmermann M, Maiteki C, Stahlfeld A, Pratt A, Mathanga DP, Staedke SG, Laufer MK, Drakeley C, Bever C, Cohee LM.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Chemoprevention by Pyrimethamine

Immunopharmacology and Immunotoxicology, 2005
The goal of the current research was to investigate the chemopreventive potency of an antimalaria drug, pyrimethamine, in in vitro conditions. The fibrosarcoma (WEHI-164) cell line was used for evaluating cytotoxicity, matrix metalloproteinase 2 (MMP-2) activity, and apoptosis. Pyrimethamine and methotrexate were used at concentrations of 0-8 microg/ml
Farshid, Saadat, Mohammad Reza, Khorramizadeh, Abbas, Mirshafiey   +2 more
openaire   +2 more sources